LULY JAY R. (President and CEO) sold 0.5% of their position (4.74K shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $67.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2025ACC: 0002064832-25-000057
DirectorOfficer· President and CEO
Since Jul 2018
-4.74K
Net shares
Net seller
$67.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.74K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.74K
Price / share
$14.23
Trade value
$67.49K
% of position
0.5%
12/5/2025
862.77K→858.03K
Total
Net shares
−4.74K
Net value
-$67.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2025 | S · Sale | −4.74K | $14.23 | $67.49K | 0.5% | 862.77K | 858.03K |
| Total | −4.74K | -$67.49K | ||||||
Derivative Transactions0
No derivative transactions reported